Midterm Outcomes of Patients with Native Heart Recovery After Impella 5+ for Cardiogenic Shock
Impella 5+ represents a promising treatment strategy for CS, providing high rates of sustained native heart recovery. A comprehensive platform of mechanical and pharmacological unloading is key.
Authors
- Marta Bandini (ORCID: https://orcid.org/0009-0004-8845-0379)
- Astrid Cardinale
- Andrea Audo
- Tommaso Capobianco
- Nicoletta D’Ettore (ORCID: https://orcid.org/0000-0002-0240-7395)
- Federico Pappalardo (ORCID: https://orcid.org/0000-0001-9129-833X)
- Alina Gallo
- Giulia Maj (ORCID: https://orcid.org/0000-0002-1928-0693)
- Walter Iannotti
Institutions
- Ospedale San Giacomo Apostolo (IT)
- Policlinico Universitario di Catania (IT)
- Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo (IT)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/ejhf.3544
- Citations
- 4
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.74
Funders
- Abiomed